Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: a systematic review and meta-analysis

References

• Wolf AV, Remp DG, Kiley JE, Currie GD. Artificial kidney function; kinetics of hemodialysis. J Clin Invest. 1951;30:1062–1070
   PubMed Web of Science ®Google Scholar
• Gejyo F, Homma N, Arakawa M. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis. Kidney Int Suppl. 1993;41:S78–S82
   Google Scholar
• de Mutsert R, Krediet RT. Malnutrition, inflammation and atherosclerosis (MIA-syndrome) in dialysis patients. Ned Tijdschr Geneeskd. 2006;150:2023–2027
   PubMedGoogle Scholar
• Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899–1911
   PubMed Web of Science ®Google Scholar
• Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648–658
   PubMed Web of Science ®Google Scholar
• Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18:1272–1280
   PubMed Web of Science ®Google Scholar
• Libetta C, Sepe V, Esposito P, Galli F, Dal Canton A. Oxidative stress and inflammation: implications in uremia and hemodialysis. Clin Biochem. 2011;44:1189–1198
   PubMed Web of Science ®Google Scholar
• Del Vecchio L, Locatelli F, Carini M. What we know about oxidative stress in patients with chronic kidney disease on dialysis – clinical effects, potential treatment, and prevention. Semin Dial. 2011;24:56–64
   PubMed Web of Science ®Google Scholar
• Panichi V, Scatena A, Migliori M, Marchetti V, Paoletti S, Beati S. Biomarkers of chronic inflammatory state in uremia and cardiovascular disease. Int J Inflam. 2012;2012:360147
   PubMedGoogle Scholar
• Elshamaa MF, Sabry S, Nabih M, Elghoroury EA, El-Saaid GS, Ismail AA. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis. Ann Nutr Metab. 2009;55:309–316
   PubMedGoogle Scholar
• deFilippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA. 2003;290:353–359
   PubMed Web of Science ®Google Scholar
• Kitabayashi C, Naruko T, Sugioka K, et al. Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease. Hemodial Int. 2013;17:557–567
   PubMedGoogle Scholar
• Sasaki M, Hosoya N, Saruhashi M. Development of vitamin E-modified membrane. Contrib Nephrol. 1999;127:49–70
   PubMedGoogle Scholar
• Calo LA, Naso A, D’Angelo A, et al. Molecular biology-based assessment of vitamin E-coated dialyzer effects on oxidative stress, inflammation, and vascular remodeling. Artif Organs. 2011;35:E33–E39
   Google Scholar
• Panagiotou A, Nalesso F, Zanella M, et al. Antioxidant dialytic approach with vitamin E-coated membranes. Contrib Nephrol. 2011;171:101–106
   PubMedGoogle Scholar
• Piroddi M, Pilolli F, Aritomi M, Galli F. Vitamin E as a functional and biocompatibility modifier of synthetic hemodialyzer membranes: an overview of the literature on vitamin E-modified hemodialyzer membranes. Am J Nephrol. 2012;35:559–572
   PubMed Web of Science ®Google Scholar
• Sosa MA, Balk EM, Lau J, et al. A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation. Nephrol Dial Transplant. 2006;21:2825–2833
   PubMedGoogle Scholar
• Mandolfo S, Corradi B, Bucci R, Farina M, Pilolli F, Galli F. Evaluation of the impact of a new synthetic vitamin E-bonded membrane on anemia and rHuEPO requirement in ESRD patients with central venous catheters: a pilot study. Int Urol Nephrol. 2012;44:1493–1500
   PubMedGoogle Scholar
• Review Manager(RevMan)[Computer program]. The Nordic Cochrane Centre. Version 5.1. Copenhagen. The Cochrane Collaboration. 2011
   Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12
   PubMedGoogle Scholar
• Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med. 2001;135:982–989
   PubMed Web of Science ®Google Scholar
• Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352:609–613
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558
   PubMed Web of Science ®Google Scholar
• Higgins JPT GSe. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011. Available from: http://www.cochrane-handbook.org
   Google Scholar
• Andrulli S, Di Filippo S, Manzoni C, et al. Effect of synthetic vitamin E-bonded membrane on responsiveness to erythropoiesis-stimulating agents in hemodialysis patients: a pilot study. Nephron Clin Pract. 2010;115:c82–c89
   PubMedGoogle Scholar
• Clermont G, Lecour S, Cabanne JF, et al. Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients. Free Radic Biol Med. 2001;31:233–241
   PubMedGoogle Scholar
• Eiselt J, Racek J, Trefil L, Opatrny K Jr. Effects of a vitamin E-modified dialysis membrane and vitamin C infusion on oxidative stress in hemodialysis patients. Artif Organs. 2001;25:430–436
   PubMedGoogle Scholar
• Kirmizis D, Papagianni A, Belechri AM, Memmos D. Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis. Nephrol Dial Transplant. 2011;26:2296–2301
   PubMedGoogle Scholar
• Morimoto H, Nakao K, Fukuoka K, et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant. 2005;20:2775–2782
   PubMedGoogle Scholar
• Nakamura T, Kawagoe Y, Matsuda T, et al. Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans. Kidney Blood Press Res. 2003;26:185–191
   PubMedGoogle Scholar
• Panichi V, Rosati A, Paoletti S, et al. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial. Blood Purif. 2011;32:7–14
   PubMedGoogle Scholar
• Tarng DC, Huang TP, Liu TY, Chen HW, Sung YJ, Wei YH. Effect of vitamin E-bonded membrane on the 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int. 2000;58:790–799
   PubMed Web of Science ®Google Scholar
• Tsuruoka S, Kawaguchi A, Nishiki K, et al. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure. Am J Kidney Dis. 2002;39:127–133
   PubMed Web of Science ®Google Scholar
• Usberti M, Gerardi G, Bufano G, et al. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis. 2002;40:590–599
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang Z. Clinical study of anti-oxidant effects of vitamin E-modified membrane on hemodialysis patients. Chin J Pract Intern Med. 2004;24:479–481 [in Chinese]
   Google Scholar
• Wang J, Liu S, Li X, Qi H, Zhuang S, Yan H. Effects of different dialyzers on oxidative stress for maintenance hemodialysis patients. Shanghai Med J. 2012;35:601–604 [in Chinese]
   Google Scholar
• Akiyama S, Inagaki M, Tsuji M, et al. Comparison of effect of vitamin E-coated dialyzer and oral vitamin E on hemodialysis-induced Cu/Zn-superoxide dismutase. Am J Nephrol. 2005;25:500–506
   PubMedGoogle Scholar
• Yang CC, Hsu SP, Wu MS, Hsu SM, Chien CT. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress. Kidney Int. 2006;69:706–714
   PubMed Web of Science ®Google Scholar
• Hegbrant J, Hultkvist Bengtsson U. Vitamin C and E as antioxidants in hemodialysis patients. Int J Artif Organs. 1999;22:69–73
   PubMed Web of Science ®Google Scholar
• Otting U, Hellmann C, Popov I, Lewin G. Equivalence values of the antioxidative capacity in serum of children with chronic renal failure, chronic hemodialysis and kidney transplantation. Z Urol Nephrol. 1990;83:189–196
   PubMedGoogle Scholar
• Tarakcioglu M, Erbagci AB, Usalan C, Deveci R, Kocabas R. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines. Mediators Inflamm. 2003;12:15–19
   PubMed Web of Science ®Google Scholar
• Borazan A, Aydemir S, Sert M, Yilmaz A. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels. Mediators Inflamm. 2004;13:361–364
   PubMedGoogle Scholar
• Popolo A, Autore G, Pinto A, Marzocco S. Oxidative stress in patients with cardiovascular disease and chronic renal failure. Free Radic Res. 2013;47:346–356
   PubMed Web of Science ®Google Scholar
• Antoniadi G, Eleftheriadis T, Liakopoulos V, et al. Effect of one-year oral alpha-tocopherol administration on the antioxidant defense system in hemodialysis patients. Ther Apher Dial. 2008;12:237–242
   PubMedGoogle Scholar
• Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science. 1922;56:650–651
   PubMedGoogle Scholar
• Muller L, Theile K, Bohm V. In vitro antioxidant activity of tocopherols and tocotrienols and comparison of vitamin E concentration and lipophilic antioxidant capacity in human plasma. Mol Nutr Food Res. 2010;54:731–742
   PubMed Web of Science ®Google Scholar
• Gotch FA. Evolution of the single-pool urea kinetic model. Semin Dial. 2001;14:252–256
   PubMed Web of Science ®Google Scholar
• Gotch F. The basic, quantifiable parameter of dialysis prescription is Kt/V urea; treatment time is determined by the ultrafiltration requirement; all three parameters are of equal importance. Blood Purif. 2007;25:18–26
   PubMedGoogle Scholar